Literature DB >> 27178323

The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages.

José Pablo Vázquez-Medina1, Chandra Dodia1, Liwei Weng2, Clementina Mesaros2, Ian A Blair2, Sheldon I Feinstein1, Shampa Chatterjee1, Aron B Fisher3.   

Abstract

Peroxiredoxin 6 (Prdx6) is essential for activation of NADPH oxidase type 2 (NOX2) in pulmonary microvascular endothelial cells (PMVECs), alveolar macrophages (AMs), and polymorphonuclear leukocytes. Angiotensin II and phorbol ester increased superoxide/H2O2 generation in PMVECs, AMs, and isolated lungs from wild-type (WT) mice, but had much less effect on cells or lungs from Prdx6-null or Prdx6-D140A-knock-in mice that lack the phospholipase A2 activity (PLA2) of Prdx6; addition of either lysophosphatidylcholine (LPC) or lysophosphatidic acid (LPA) to cells restored their oxidant generation. The generation of LPC by PMVECs required Prdx6-PLA2 We propose that Prdx6-PLA2 modulates NOX2 activation by generation of LPC that is converted to LPA by the lysophospholipase D activity of autotaxin (ATX/lysoPLD). Inhibition of lysoPLD with HA130 (cells,10 μM; lungs, 20 μM; IC50, 29 nM) decreased agonist-induced oxidant generation. LPA stimulates pathways regulated by small GTPases through binding to G-protein-coupled LPA receptors (LPARs). The LPAR blocker Ki16425 (cells, 10 μM; lungs, 25 μM; Ki, 0.34 μM) or cellular knockdown of LPAR type 1 decreased oxidant generation and blocked translocation of rac1 to plasma membrane. Thus, Prdx6-PLA2 modulates NOX2 activation through generation of LPC for conversion to LPA; binding of LPA to LPAR1 signals rac activation.-Vázquez-Medina, J. P., Dodia, C., Weng, L., Mesaros, C., Blair, I. A., Feinstein, S. I., Chatterjee, S., Fisher, A. B. The phospholipase A2 activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages. © FASEB.

Entities:  

Keywords:  G-protein-coupled receptors; autotaxin; lysophosphatidylcholine; lysophospholipase D; rac

Mesh:

Substances:

Year:  2016        PMID: 27178323      PMCID: PMC4970605          DOI: 10.1096/fj.201500146R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  75 in total

1.  Cell-free NADPH oxidase activation assays: "in vitro veritas".

Authors:  Edgar Pick
Journal:  Methods Mol Biol       Date:  2014

2.  Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz; Alfiya Bikineyeva; Lula Hilenski; Bernard Lassègue; Kathy K Griendling; David G Harrison; Anna E Dikalova
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

Review 3.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

4.  Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium.

Authors:  Christopher C Silliman; David J Elzi; Daniel R Ambruso; Rene J Musters; Christine Hamiel; Ronald J Harbeck; Andrew J Paterson; A Jason Bjornsen; Travis H Wyman; Marguerite Kelher; Kelly M England; Nathan McLaughlin-Malaxecheberria; Carlton C Barnett; Junichi Aiboshi; Anirban Bannerjee
Journal:  J Leukoc Biol       Date:  2003-04       Impact factor: 4.962

Review 5.  Pulmonary endothelial cell NOX.

Authors:  Rachel Damico; Javier J Zulueta; Paul M Hassoun
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-12       Impact factor: 6.914

Review 6.  Phospholipase A2.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

7.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

8.  Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox).

Authors:  Xiaoxian Zhao; Erik A Bey; Frans B Wientjes; Martha K Cathcart
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

9.  Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

Authors:  Hideo Ohta; Koichi Sato; Naoya Murata; Alatangaole Damirin; Enkhzol Malchinkhuu; Junko Kon; Takao Kimura; Masayuki Tobo; Yuji Yamazaki; Tomoko Watanabe; Mikio Yagi; Motoko Sato; Rika Suzuki; Hideko Murooka; Teruyuki Sakai; Tsuyoshi Nishitoba; Dong-Soon Im; Hiromi Nochi; Koichi Tamoto; Hideaki Tomura; Fumikazu Okajima
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

10.  Unsaturated fatty acids as second messengers of superoxide generation by macrophages.

Authors:  Y Bromberg; E Pick
Journal:  Cell Immunol       Date:  1983-07-15       Impact factor: 4.868

View more
  24 in total

1.  Extracellular adenosine-induced Rac1 activation in pulmonary endothelium: Molecular mechanisms and barrier-protective role.

Authors:  Anita Kovacs-Kasa; Kyung Mi Kim; Mary Cherian-Shaw; Stephen M Black; David J Fulton; Alexander D Verin
Journal:  J Cell Physiol       Date:  2018-03-07       Impact factor: 6.384

Review 2.  NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Authors:  Richmond Muimo; Hani Mm Alothaid; Anil Mehta
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

3.  Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury.

Authors:  Ying Shao; Gayani Nanayakkara; Jiali Cheng; Ramon Cueto; William Y Yang; Joon-Young Park; Hong Wang; Xiaofeng Yang
Journal:  Antioxid Redox Signal       Date:  2017-04-26       Impact factor: 8.401

4.  Comparison of Whole Body SOD1 Knockout with Muscle-Specific SOD1 Knockout Mice Reveals a Role for Nerve Redox Signaling in Regulation of Degenerative Pathways in Skeletal Muscle.

Authors:  Giorgos K Sakellariou; Brian McDonagh; Helen Porter; Ifigeneia I Giakoumaki; Kate E Earl; Gareth A Nye; Aphrodite Vasilaki; Susan V Brooks; Arlan Richardson; Holly Van Remmen; Anne McArdle; Malcolm J Jackson
Journal:  Antioxid Redox Signal       Date:  2017-12-12       Impact factor: 8.401

Review 5.  Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling.

Authors:  Aron B Fisher
Journal:  Arch Biochem Biophys       Date:  2016-12-06       Impact factor: 4.013

6.  Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.

Authors:  José Pablo Vázquez-Medina; Jian-Quin Tao; Priyal Patel; Renata Bannitz-Fernandes; Chandra Dodia; Elena M Sorokina; Sheldon I Feinstein; Shampa Chatterjee; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

7.  Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2β (Group VIA Phospholipase A2).

Authors:  Jason W Ashley; William D Hancock; Alexander J Nelson; Robert N Bone; Hubert M Tse; Mary Wohltmann; John Turk; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

8.  The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism.

Authors:  Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen
Journal:  Antioxid Redox Signal       Date:  2019-11-01       Impact factor: 8.401

Review 9.  The phospholipase A2 activity of peroxiredoxin 6.

Authors:  Aron B Fisher
Journal:  J Lipid Res       Date:  2018-05-01       Impact factor: 5.922

10.  Lysophospholipids in Lung Inflammatory Diseases.

Authors:  Jing Zhao; Yutong Zhao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.